WO2007082047A2 - Therapeutic laser treatment - Google Patents
Therapeutic laser treatment Download PDFInfo
- Publication number
- WO2007082047A2 WO2007082047A2 PCT/US2007/000786 US2007000786W WO2007082047A2 WO 2007082047 A2 WO2007082047 A2 WO 2007082047A2 US 2007000786 W US2007000786 W US 2007000786W WO 2007082047 A2 WO2007082047 A2 WO 2007082047A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- selected tissue
- tissue
- laser light
- laser
- treatment
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title description 9
- 238000013532 laser treatment Methods 0.000 title description 6
- 238000011282 treatment Methods 0.000 claims abstract description 102
- 238000000034 method Methods 0.000 claims abstract description 45
- 230000001427 coherent effect Effects 0.000 claims abstract description 19
- 208000001640 Fibromyalgia Diseases 0.000 claims description 6
- 229910052779 Neodymium Inorganic materials 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 6
- 208000033808 peripheral neuropathy Diseases 0.000 claims description 6
- 208000006011 Stroke Diseases 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 208000023275 Autoimmune disease Diseases 0.000 claims description 3
- 208000019695 Migraine disease Diseases 0.000 claims description 3
- 206010072005 Spinal pain Diseases 0.000 claims description 3
- 206010052428 Wound Diseases 0.000 claims description 3
- 208000027418 Wounds and injury Diseases 0.000 claims description 3
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 3
- 210000005036 nerve Anatomy 0.000 claims description 3
- 230000000926 neurological effect Effects 0.000 claims description 3
- 230000000472 traumatic effect Effects 0.000 claims description 3
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 claims description 3
- 208000030507 AIDS Diseases 0.000 claims description 2
- 208000008035 Back Pain Diseases 0.000 claims description 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims description 2
- 208000018652 Closed Head injury Diseases 0.000 claims description 2
- 208000013586 Complex regional pain syndrome type 1 Diseases 0.000 claims description 2
- 206010010254 Concussion Diseases 0.000 claims description 2
- 206010011219 Costochondritis Diseases 0.000 claims description 2
- 206010012434 Dermatitis allergic Diseases 0.000 claims description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 claims description 2
- 208000028389 Nerve injury Diseases 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims description 2
- 208000018262 Peripheral vascular disease Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 claims description 2
- 208000005793 Restless legs syndrome Diseases 0.000 claims description 2
- 208000008765 Sciatica Diseases 0.000 claims description 2
- 208000026317 Tietze syndrome Diseases 0.000 claims description 2
- 208000030886 Traumatic Brain injury Diseases 0.000 claims description 2
- 208000000558 Varicose Ulcer Diseases 0.000 claims description 2
- 230000009514 concussion Effects 0.000 claims description 2
- 208000029078 coronary artery disease Diseases 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 206010022000 influenza Diseases 0.000 claims description 2
- 206010025135 lupus erythematosus Diseases 0.000 claims description 2
- 201000006417 multiple sclerosis Diseases 0.000 claims description 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims description 2
- 230000008764 nerve damage Effects 0.000 claims description 2
- 230000011514 reflex Effects 0.000 claims description 2
- 208000020431 spinal cord injury Diseases 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 206010044652 trigeminal neuralgia Diseases 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 claims 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 claims 1
- 206010027603 Migraine headaches Diseases 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- MSTPNDZQVGSTET-UHFFFAOYSA-M sodium;2-anilino-6-sulfanylidene-1h-1,3,5-triazine-4-thiolate Chemical compound [Na+].N1C(=S)N=C([S-])N=C1NC1=CC=CC=C1 MSTPNDZQVGSTET-UHFFFAOYSA-M 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 56
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 description 22
- 230000003287 optical effect Effects 0.000 description 10
- 210000002683 foot Anatomy 0.000 description 8
- 210000003423 ankle Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 229910019655 synthetic inorganic crystalline material Inorganic materials 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000035154 Hyperesthesia Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010067152 Oral herpes Diseases 0.000 description 2
- 208000026062 Tissue disease Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000003685 thermal hair damage Effects 0.000 description 2
- QWVYNEUUYROOSZ-UHFFFAOYSA-N trioxido(oxo)vanadium;yttrium(3+) Chemical compound [Y+3].[O-][V]([O-])([O-])=O QWVYNEUUYROOSZ-UHFFFAOYSA-N 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010048744 Fear of falling Diseases 0.000 description 1
- 208000018650 Intervertebral disc disease Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010061223 Ligament injury Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010070757 Muscle contusion Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 229910017502 Nd:YVO4 Inorganic materials 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 206010040030 Sensory loss Diseases 0.000 description 1
- 208000020339 Spinal injury Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 206010043269 Tension headache Diseases 0.000 description 1
- 208000008548 Tension-Type Headache Diseases 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 229910009372 YVO4 Inorganic materials 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000001764 biostimulatory effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940000032 cardiovascular system drug Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000002988 lumbosacral plexus Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007433 nerve pathway Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000513 rotator cuff Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
Definitions
- This invention relates to a method and apparatus for treating biological tissue using therapeutic laser techniques.
- Monochromatic light coming from a laser is of the same wavelength, and the coherent characteristic of laser light typically refers to the waves making up the laser light having the same direction, amplitude, and phase with respect to one another.
- Lasers used for medical treatments typically fall into several groups. For example, “hot” lasers are typically used in surgery, and “mid-power” lasers may be used in photodynamic therapy for cancer treatment, dermatological treatments, etc.
- Low energy lasers generally deliver significantly less energy to tissue than surgical lasers and mid-power, and accordingly, produce relatively little heat in biological tissue such that the tissue is not subjected to thermal damage. Low energy lasers have been used for dermatology treatments, traumatology, and in other areas for enhancing healing and providing therapeutic benefits.
- the present invention includes a method and apparatus for treating selected tissue, and includes exposing the selected tissue to laser light having a wavelength between approximately 600 and 1400 nm, and maintaining such exposure of the selected tissue to the laser light for a period of time sufficient to deliver a laser light dosage of at least 7 Joules/cm per treatment to the selected tissue, and the treatment area may be in the range of 500 cm 2 .
- the present invention also includes a method for treating selected tissue, which includes the combination of exposing the selected tissue to laser light having a wavelength between approximately 600 to 1400 ran and upcollimating the laser light such that the laser delivers to the selected tissue a substantially coherent beam of laser light having a cross-sectional area of at least 2 cm 2 .
- the present invention further includes a method for treating tissue, comprising exposing tissue to a laser light of a wavelength between approximately 600 to 1400 nm at a power density of at least 300 mW/cm 2 , and maintaining such exposure of the tissue to the laser light for a period of time sufficient to deliver a laser light dosage of at least 7 Joules/cm 2 , and further, delivering the laser light to a depth of at least 5 mm in the selected tissue for treating same.
- the present invention includes a method for treating tissue, including exposing the selected tissue to laser light at a wavelength of approximately 1,064 nm and at a power density of at least 300 mW/cm 2 , and upcollimating the laser light to deliver a substantially coherent beam of laser light having a cross-sectional area of approximately 10 cm 2 to the selected tissue, and further, maintaining the exposure of the selected tissue to the laser light for a period of time sufficient to deliver a laser light dosage to the tissue of at least 1500 Joules per treatment within a 24 hour period.
- the present invention includes an apparatus for therapeutic treatment of biological tissue including a laser device, preferably a neodymium doped yttrium-aluminum-garnet (Nd:YAG) laser or a neodymium doped yttrium vanadate (Nd: YVO4) laser.
- the laser preferably delivers light at a wavelength of between 600 and 1400 nanometers (nm), and provides a laser beam for treatment of tissue in a range of 1 Joules/cm 2 to 200 Joules/cm 2 .
- a beam expander and/or a collimator is connected to the laser in order to increase the cross-sectional area of the laser beam and for maintaining the laser beam coherent and monochromatic.
- the beam's cross-sectional output is changed from 1 A cm 2 to a cross-sectional output usable in treating the entire body of the patient (by using one or more collimators large enough to expose the entire body of the patient simultaneously) and/or by moving the laser in a grid-like pattern during treatment of the patient with the laser.
- the output of laser device is preferably in the range from 1 mW/cm 2 to at least 500 mW/cm 2 and is preferably configured such that treatment times for exposing biological tissue can be varied from one second or less to continuous, i.e., 24 hours a day for the desired number of days, or portions thereof.
- an apparatus for therapeutic laser treatment in accordance with the present invention is indicated generally in the figure by reference character 10.
- a laser system for conducting therapeutic laser treatment is shown, and includes a laser, which, in one preferred embodiment, is a neodymium doped yttrium-aluminum-garnet (Nd:YAG) laser or a neodymium doped yttrium vanadate (Nd:YVO4) laser device, or probe, generally, 12, which emits a laser beam 14.
- Laser device 12 preferably delivers optical radiation in the form of laser light at a wavelength of between 600 and 1400 nanometers (ran), and provides a laser beam 14 in the range from 1 mW/cm 2 to at lease 500 mW/cm 2 .
- Laser system 10 is configured such that, treatment times for exposing human and/or animal tissue can be varied from one second or less to continuous, i.e., 24 hours a day for the desired number of days, or portions thereof.
- Treatments in accordance with the present invention preferably range between 1 Joules/cm 2 to 400 Joules/cm 2 , and most preferably involve in most cases exposing the tissue to at least 7 Joules/cm 2 of laser exposure and maintaining the exposure of the selected tissue to the laser light for a period of time sufficient to deliver a laser light dosage to the tissue of at least 1500 Joules per treatment within a 24 hour period.
- treatments within a 24 hour period may exceed 32,000 Joules, and such treatments may be repeated daily.
- laser device 12 has a wavelength of 1064 nanometers in the near infrared region of the electromagnetic spectrum.
- the energy of the optical radiation is controlled and applied to produce a minimum absorption rate in the irradiated tissue to minimize elevation of the average temperature of the irradiated tissue to a level above the basal body temperature and in no event to the extent the maximum absorption rate is great enough to convert the irradiated tissue into a collagenous substance.
- Nd YAG laser operated at its fundamental wavelength of 1064 nanometers at a power output level of from 100-1000 milliwatts/cm 2 , with the laser beam being focused to produce a power density of the projected laser beam in the range of from about 100 mW/cm 2 to about 1000 mW/cm 2 .
- Laser system 10 could also include, if desired, an aiming laser (not shown) to facilitate use in aiming the laser beam 14 of laser device, generally 12, at a target, generally 16.
- Target 16 is a generalized representation the desired treatment area of human or animal tissue to be irradiated by laser beam 14, in a manner described below.
- a collimator 20 is connected to laser 12 in order to allow the size of laser beam
- the beam size can be changed from 1 A cm 2 to a cross-sectional output usable in treating the entire body of the patient by using one or more collimators large enough to expose the entire body of the patient simultaneously (except for areas which do not require and/or should not receive laser treatment exposure, such as the patient's eyes, etc.) and/or by moving laser 12 in a grid-like pattern during treatment of the patient.
- laser system 12 is illustrated herein as using a fiber optic cable 18, a series of mirrors (not shown) could be used instead of, or in combination with, cable 18 to direct the laser beam 14 to target 16, if desired.
- a laser device could be provided having an output beam with a cross-sectional area of 10 cm or more, without exceeding an output of 600 mW/cm 2
- Laser system 10 also includes a power supply, control unit, and resonator, collectively generally 22, having a control panel, generally 24, for controlling the operation output of laser device 12.
- Unit 22 preferably includes a processor for allowing for preprogrammed laser treatments to be executed using laser device 12, such programs being selectable from control panel 24 having a keypad or other data entry device.
- a foot pedal (not shown) and/or a handheld controller, generally 26, is connected to laser device 12 having controls, generally 28, for allowing a healthcare provider, technician, etc., to control laser 12 remotely from control panel 24, if desired.
- Controller 26 may include a keyed lock-out switch 30 having a key 32 in order to prevent unauthorized operation of laser device 12.
- control box 28 could include a keypad (not shown) for entering a desired treatment protocol to be delivered by laser device 12 and/or for allowing a personal identification number (PIN), authorization codes, biometric identifier such as a fingerprint reader, etc., to be entered by a healthcare provider or technician in order to operate laser device 12, if desired.
- controller 26 could be wirelessly connected to control unit 22, as could also laser device 12.
- Laser device 12 is, in one preferred embodiment, connected to an articulated arm 36 which allows for flexibility in manipulating and aiming laser device 12 at a particular target. It is to be understood, however, that laser system 10 is not limited to articulated arm 36, and could be mounted in a variety of other configurations, if desired, and/or be handheld by the healthcare provider, if desired.
- the present invention is not limited to the laser device 12 shown, but could be a variety of other sizes, as could also collimator 20, and could be configured for exposing a target 16 of a variety of sizes, including a full body exposure of a patient.
- Articulated arm 36 is mounted on base 38, although it could be mounted on a wall, ceiling, floor, examination table, etc., if desired.
- laser system 10 could be portable, such that it may be carried by hand, and/or mounted on a wheeled cart, or other base, for facilitating transport within a medical facility, in the field, or in other environments.
- the present invention includes methods and protocols for using laser energy at elevated dosages in order to achieve therapeutic benefit while refraining from damaging the tissue being treated.
- the nature and extent of the tissue disorder is first diagnosed and the location, size, and number of treatment area(s) is established. Thereafter, the treatment area(s) is exposed to monochromatic, coherent light below the level necessary to cause thermal damage to the tissue being treated, wherein the light is in the near infrared portion of the electromagnetic spectrum. The treatment area is exposed to the monochromatic, coherent light for a sufficient treatment time to produce clinically beneficial effects by delivering a dosage typically greater than 7 Joules/cm 2 .
- monochromatic light refers to light which is of the same wavelength, and coherent means that the waves of light have similar direction, amplitude, and phase to each other.
- monochromatic, coherent light having a wavelength in the 600 to 1400 nanometer (nm) range is used in the treatment of soft tissue, bone, and/or body fluids and other disorders by irradiating a treatment area for sufficient time to produce clinically beneficial effects. It is contemplated dosages in the range of approximately 7 Joules/cm 2 to approximately 40 Joules/cm 2 are preferred, although even higher dosages could be given without departing from the spirit of the present invention.
- a dosage of approximately 10 Joules/cm 2 is delivered to the tissue. Additional treatments and treatment areas maybe treated as determined by the diagnosing physician or other health care provider.
- the wavelength of laser light is the basic electromagnetic wave feature directly linked to the energy of an individual light quantum (photon).
- Photon individual light quantum
- Wavelengths in the range of preferably between 600 to 1400 nm are used in the present invention, although wavelengths in the range of 400 to 10,000 nm could also be used, depending on the particular treatment.
- tissue optical parameters reflection, scattering, refraction, absorption and depth penetration
- Intensity is the rate of light energy delivery to 1 cm 2 of skin or other tissue.
- Intensity is measured in milliWatts per cm 2 (mW/cm 2 ). Suitable intensities for biostimulation are known to be in the range of from 0.1 to 1 ,000 mW/cm 2 .
- dose means the light energy provided to the unit of surface (1 cm 2 ) of target 16 during a single irradiation and measured in J/cm 2 or mJ/ cm 2 .
- a laser generating 10 Watts of output power may be used to deliver optical energy to a 20 cm 2 treatment area. This produces an intensity, or power density, of 500 mW/cm 2 , which is currently the maximum intensity permitted by the U.S. Food and Drug Administration (FDA).
- FDA U.S. Food and Drug Administration
- optical parameters including the type of the light source, optical power, intensity, dose, frequency and pulse duration, wavelength and bandwidth, beam diameter and divergence, three- dimensional light distribution, etc. which may be selected to provide an optimized protocol to treat the disorder.
- the method in accordance with the present invention is adapted for the therapeutic treatment of any of a patient's tissue, which includes muscle, nerve, bone, body fluids (including spinal fluid), epithelial, and/or connective tissues.
- the method is adapted for the relief of acute and chronic soft tissue trauma and to provide musculoskeletal pain management.
- a wide range of disorders of biological tissue or their symptoms may be treated by laser system 10, including the following:
- Musculoskeletal conditions such as: degenerative joint disease, traumatic joint and ligament injury, such as rotator cuff, ankle sprain, knee strain, tennis elbow, golf elbow, TMJ, muscle contusions, bone fracture, fibromyalgia, and costochondritis;
- Neurological conditions such as: peripheral neuropathy, reflex sympathetic dystrophy, trigeminal neuralgia, migraine headache, stroke, concussions, plantar fascititis, radiculopathy, spinal injury, peripheral neuropathy, sciatica, traumatic nerve injury, diabetic nerve, restless leg syndrome, and tension and migraine headache;
- Wound treatment such as: post op healing, decubitis wound sores, burns (first degree and full thickness); stasis ulcers, allergic rashes (example, poison ivy etc.), and insect bites;
- Pain management such as: spinal pain from herniated or bulging disc, back pain from musculoskeletal strain, reflex symphatic dystrophy, fibromyalgia, pain from musculoskeletal items listed; and
- Viral infections such as: herpes, all types (including mononucleosis) and acquired immune deficiency syndrome (ADDS); and autoimmune diseases, such as: multiple sclerosis, psoriasis, rhumatoid diseases, chronic fatigue syndrome, Parkinson's disease, and lupus.
- Treatment in accordance with the present invention is also anticipated to meet with success in treatment of other neurological conditions, such as: stroke, closed head injury, and spinal cord injury; in cardio vascular system conditions, such as: coronary artery disease and peripheral vascular disease; in viral infection applications, such as viral flu syndromes; and in connection with autoimmune diseases, such as diabetes, ALS, and others.
- other neurological conditions such as: stroke, closed head injury, and spinal cord injury
- cardio vascular system conditions such as: coronary artery disease and peripheral vascular disease
- viral infection applications such as viral flu syndromes
- autoimmune diseases such as diabetes, ALS, and others.
- the tissue to be treated is irradiated with optical energy.
- the treatment with optical energy is believed to increase microcirculation and creates biostimulative effects at the cellular level.
- Photobiostimulation occurs when monochromatic, coherent light acts on the photoacceptor molecules within the cells of the tissue being treated.
- a diode-pumped, solid-state Nd: YAG laser is used as the source of this optical energy, producing optical energy in the form of light at 1064 nm wavelength.
- This light is guided through fiber optic cable 18 collimator 20 with an aperture sized appropriately for the desired treatment area and the time necessary to cover the treatment area.
- the aperture of collimator 20 is circular, with an area of 10 cm 2 , and this embodiment is particularly adapted for application to a treatment target site of approximately 10 cm 2 .
- the physician After diagnosing the nature and extent of a tissue disorder, the physician preferably establishes the location, size, and number of treatment areas.
- the size of the treatment areas is approximately 10 cm 2 , although the treatment area may range from between approximately 0.1 cm 2 to entire body of the patient.
- the laser aperture is accordingly adjusted to accommodate the different treatment site sizes, and the treatment sites are treated by exposing them to monochromatic, coherent light from laser device 12. Larger areas may be treated by moving laser device 12 and collimator over the entire area in a grid-ljke fashion.
- duration for treatment time can be continuous, i.e., up to
- the treatment may be a single treatment or may be repeated daily, or periodically for a prescribed number of days necessary to produce clinically beneficial effects.
- a single laser device 12 can be used for tender points, trigger points, selected points in the affected area, points on the skin overlying the treatment target (e.g. tendon, spur, calcification deposit), spinal nerve roots, points on the skin overlying selected nerve pathways and other localized (e.g. acupuncture) points.
- laser device 12 of the present invention may be constructed of flexible plastic (not shown) or other suitable material to be wrapped around the surface contours of the body.
- the laser device may be formed in the shape of a ring (not shown), having light sources arranged on its inner surface, to apply treatment to a finger or other extremity-
- laser device 12 is applied directly to the skin surface.
- laser device 12 is applied to the skin surface with pressure. This technique allows deeper light penetration to the tissue, since light scattering is generally significantly less in compressed tissue, and light absorption by blood is less because blood is partially squeezed out of the compressed tissue.
- the scanning technique is used for the treatment of large areas with laser devices.
- the laser device is moved by the health care provider along the skin surface with definite speed and the affected area is irradiated by a laser beam.
- This technique is used when the area to be treated is large, and preferably involves use of one or more collimators 20.
- the use of monochromatic, collimated laser light at approximately 1064 nm, at an intensity of 500m W/cm 2 is believed to allow the beneficial effects of laser light to penetrate deeper than heretofore practiced, in that the laser light is not so readily absorbed and dissipated prior to reaching the targeted tissue, which may reach down to the bone.
- the majority of treatments in accordance with the present invention involve exposing the tissue to at least 7 Joules/cm 2 of laser exposure for a period of time sufficient to deliver a laser light dosage of at least 1500 Joules to the tissue, per treatment within a 24 hour period.
- treatments within a 24 hour period may exceed 32,000 Joules, and such treatments may be repeated daily.
- Example 2 The patient presented with chronic neck pain and unable to raise his hands above 90 degrees in the lateral plane without significant pain. He had been to numerous clinics in the past, including pain clinics, chiropractors, etc. without relief. A physical examination revealed bilateral tenderness in both subscapular areas, as well as moderate swelling of the soft tissues. The treatment with a laser included the patient receiving 2 treatments bilaterally along the subscapular region, with total treatment time being approximately 20 minutes in length. There was a five day separation in treatment protocols. The results were that after the third treatment day, there was a 90% reduction in pain with motion, and after the tenth treatment day of treatment, the patient stated he was free of pain and had no movement restrictions.
- the patient was presumed to have chronic arthritic pain, as no neurological symptoms were present, and an MRI showed no disc disease.
- the patient had less than 30 degrees of rotation to the left and 45 degrees to the right.
- the patient received 10 treatments of approximately 20 minutes each to the cervical areas three through seven. At the end of the treatment, the patient had 80 degrees of rotation bilaterally.
- Pre-treatment parameters included 30 degree flexion and significant pain with ambulation, especially when walking stairs.
- the patient also experienced difficult ambulation upon rising in the morning.
- the treatment protocol included the patient receiving ten 20 minute treatments. He received five consecutive treatments, followed by five days without treatment, and then five more similar treatments. Post treatment measurements yielded flexion at 95 degrees with no pain in climbing stairs, no early morning pain, and generally unlimited ambulation.
- Example 6 A 60 year old male physician presented with an undiagnosed peripheral neuropathy which manifested with symptoms including loss of sensation and prior perception of his lower extremities.
- the patient was a prominent physician and on the board of major university medical system, and had undergone multiple tests with numerous specialists. No specific diagnosis was ever established except "peripheral neuropathy". This problem had been present for over 15 years, and the doctor felt that his symptoms were progressing.
- the treatment protocol consisted of daily exposure to the laser over the entire length of his spinal cord, as well as over the lumbar plexus. Each session lasted approximately 30 minutes. The length of the total sessions was five days, followed by 10 days of rest, and the process was then repeated. After the second cycle of treatments, the patient reported a significant change is his ability to "feel" his legs.
Abstract
A method for treating selected tissue, including exposing the selected bone or tissue to laser light having a wavelength between approximately 600 and 1400 nm, and maintaining such exposure of the selected tissue or bone to the laser light for a period of time sufficient to deliver a laser light dosage of at least 7 Joules/cm2 per treatment and maintaining such exposure for a period of time sufficient to deliver a laser light dosage of at least 1500 Joules per treatment within a 24 hour period of time. The method also includes upcollimating the laser light such that the laser delivers to the selected tissue a substantially coherent beam of laser light having a cross-sectional area of at least 2 cm2, and, further, delivering the laser light to a depth of at least 5 mm in the selected tissue.
Description
THERAPEUTICLASERTREATMENT BACKGROUND OFTHEINVENTION
This invention relates to a method and apparatus for treating biological tissue using therapeutic laser techniques.
Lasers provide monochromatic light, and have found a number of uses in the field of medicine. Monochromatic light coming from a laser is of the same wavelength, and the coherent characteristic of laser light typically refers to the waves making up the laser light having the same direction, amplitude, and phase with respect to one another.
Lasers used for medical treatments typically fall into several groups. For example, "hot" lasers are typically used in surgery, and "mid-power" lasers may be used in photodynamic therapy for cancer treatment, dermatological treatments, etc.
"Low energy" lasers generally deliver significantly less energy to tissue than surgical lasers and mid-power, and accordingly, produce relatively little heat in biological tissue such that the tissue is not subjected to thermal damage. Low energy lasers have been used for dermatology treatments, traumatology, and in other areas for enhancing healing and providing therapeutic benefits.
Due to scattering, laser light may begin to lose coherence and its monochromatic characteristics upon entering tissue. Thus, using conventional techniques and equipment, deeper biological tissue may not be able to distinguish laser light and thus potentially not benefit therefrom. SUMMARY OF THE INVENTION
Generally, the present invention includes a method and apparatus for treating selected tissue, and includes exposing the selected tissue to laser light having a wavelength between approximately 600 and 1400 nm, and maintaining such exposure of the selected tissue to the laser light for a period of time sufficient to deliver a laser light dosage of at least 7 Joules/cm per treatment to the selected tissue, and the treatment area may be in the range of 500 cm2.
The present invention also includes a method for treating selected tissue, which includes the combination of exposing the selected tissue to laser light having a
wavelength between approximately 600 to 1400 ran and upcollimating the laser light such that the laser delivers to the selected tissue a substantially coherent beam of laser light having a cross-sectional area of at least 2 cm2.
The present invention further includes a method for treating tissue, comprising exposing tissue to a laser light of a wavelength between approximately 600 to 1400 nm at a power density of at least 300 mW/cm2, and maintaining such exposure of the tissue to the laser light for a period of time sufficient to deliver a laser light dosage of at least 7 Joules/cm2, and further, delivering the laser light to a depth of at least 5 mm in the selected tissue for treating same. More specifically, the present invention includes a method for treating tissue, including exposing the selected tissue to laser light at a wavelength of approximately 1,064 nm and at a power density of at least 300 mW/cm2, and upcollimating the laser light to deliver a substantially coherent beam of laser light having a cross-sectional area of approximately 10 cm2 to the selected tissue, and further, maintaining the exposure of the selected tissue to the laser light for a period of time sufficient to deliver a laser light dosage to the tissue of at least 1500 Joules per treatment within a 24 hour period.
Additionally, the present invention includes an apparatus for therapeutic treatment of biological tissue including a laser device, preferably a neodymium doped yttrium-aluminum-garnet (Nd:YAG) laser or a neodymium doped yttrium vanadate (Nd: YVO4) laser. The laser preferably delivers light at a wavelength of between 600 and 1400 nanometers (nm), and provides a laser beam for treatment of tissue in a range of 1 Joules/cm2 to 200 Joules/cm2. A beam expander and/or a collimator is connected to the laser in order to increase the cross-sectional area of the laser beam and for maintaining the laser beam coherent and monochromatic. Preferably, use of different collimators allow the beam's cross-sectional output to be changed from 1A cm2 to a cross-sectional output usable in treating the entire body of the patient (by using one or more collimators large enough to expose the entire body of the patient simultaneously) and/or by moving the laser in a grid-like pattern during treatment of the patient with the laser. The output of laser device is preferably in the range from 1 mW/cm2 to at least 500 mW/cm2 and is preferably configured such that treatment times for exposing
biological tissue can be varied from one second or less to continuous, i.e., 24 hours a day for the desired number of days, or portions thereof.
BRIEF DESCRIPTION OF THE DRAWING The foregoing, as well as other objects of the present invention, will be further apparent from the following detailed description of the preferred embodiment of the invention, when taken together with the accompanying specification and the drawings, in which the figure is a perspective view of an apparatus for providing therapeutic laser treatment constructed in accordance with the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENT
The foregoing, as well as other objects of the present invention, will be further apparent from the following detailed description of the preferred embodiment of the invention, when taken together with the accompanying drawings and the description which follows set forth this invention in its preferred embodiment. However, it is contemplated that persons generally familiar with the use of lasers for medical treatment will be able to apply the novel characteristics of the structures and methods illustrated and described herein in other contexts by modification of certain details. Accordingly, the drawing and description are not to be taken as restrictive on the scope of this invention, but are to be understood as broad and general teachings.
Referring now to the drawing in detail, an apparatus for therapeutic laser treatment in accordance with the present invention is indicated generally in the figure by reference character 10.
In the figure, a laser system, generally 10, for conducting therapeutic laser treatment is shown, and includes a laser, which, in one preferred embodiment, is a neodymium doped yttrium-aluminum-garnet (Nd:YAG) laser or a neodymium doped yttrium vanadate (Nd:YVO4) laser device, or probe, generally, 12, which emits a laser beam 14. Laser device 12 preferably delivers optical radiation in the form of laser light at a wavelength of between 600 and 1400 nanometers (ran), and provides a laser beam 14 in the range from 1 mW/cm2 to at lease 500 mW/cm2. Laser system 10 is configured such that, treatment times for exposing human and/or animal tissue can be varied from one second or less to continuous, i.e., 24 hours a day for the desired number of days, or
portions thereof. Treatments in accordance with the present invention preferably range between 1 Joules/cm2 to 400 Joules/cm2, and most preferably involve in most cases exposing the tissue to at least 7 Joules/cm2 of laser exposure and maintaining the exposure of the selected tissue to the laser light for a period of time sufficient to deliver a laser light dosage to the tissue of at least 1500 Joules per treatment within a 24 hour period. In certain applications, for example, when treating fever blisters, fibromyalgia, etc., treatments within a 24 hour period may exceed 32,000 Joules, and such treatments may be repeated daily.
In one preferred embodiment, laser device 12 has a wavelength of 1064 nanometers in the near infrared region of the electromagnetic spectrum. The energy of the optical radiation is controlled and applied to produce a minimum absorption rate in the irradiated tissue to minimize elevation of the average temperature of the irradiated tissue to a level above the basal body temperature and in no event to the extent the maximum absorption rate is great enough to convert the irradiated tissue into a collagenous substance.
It has been determined through extensive testing that the foregoing condition is satisfied by a Nd: YAG laser operated at its fundamental wavelength of 1064 nanometers at a power output level of from 100-1000 milliwatts/cm2, with the laser beam being focused to produce a power density of the projected laser beam in the range of from about 100 mW/cm2 to about 1000 mW/cm2.
Laser system 10 could also include, if desired, an aiming laser (not shown) to facilitate use in aiming the laser beam 14 of laser device, generally 12, at a target, generally 16. Target 16 is a generalized representation the desired treatment area of human or animal tissue to be irradiated by laser beam 14, in a manner described below. A collimator 20 is connected to laser 12 in order to allow the size of laser beam
14, carried by fiber optic cable 18, to be increased, while still maintaining and enhancing the coherency and monochromacity of laser beam 14. Preferably, by selection of an appropriate collimator 20 and/or through the use of multiple collimators, the beam size can be changed from 1A cm2 to a cross-sectional output usable in treating the entire body of the patient by using one or more collimators large enough to expose the entire body of the patient simultaneously (except for areas which do not require and/or should not receive laser treatment exposure, such as the patient's eyes, etc.) and/or by moving laser
12 in a grid-like pattern during treatment of the patient. It is to be understood, however, that while laser system 12 is illustrated herein as using a fiber optic cable 18, a series of mirrors (not shown) could be used instead of, or in combination with, cable 18 to direct the laser beam 14 to target 16, if desired. Alternately, instead of using a collimator, it is believed that a laser device could be provided having an output beam with a cross-sectional area of 10 cm or more, without exceeding an output of 600 mW/cm2
Laser system 10 also includes a power supply, control unit, and resonator, collectively generally 22, having a control panel, generally 24, for controlling the operation output of laser device 12. Unit 22 preferably includes a processor for allowing for preprogrammed laser treatments to be executed using laser device 12, such programs being selectable from control panel 24 having a keypad or other data entry device. Also, in one preferred embodiment, a foot pedal (not shown) and/or a handheld controller, generally 26, is connected to laser device 12 having controls, generally 28, for allowing a healthcare provider, technician, etc., to control laser 12 remotely from control panel 24, if desired. Controller 26 may include a keyed lock-out switch 30 having a key 32 in order to prevent unauthorized operation of laser device 12. Instead of, or in addition to a key 32, control box 28 could include a keypad (not shown) for entering a desired treatment protocol to be delivered by laser device 12 and/or for allowing a personal identification number (PIN), authorization codes, biometric identifier such as a fingerprint reader, etc., to be entered by a healthcare provider or technician in order to operate laser device 12, if desired. Also, controller 26 could be wirelessly connected to control unit 22, as could also laser device 12.
Laser device 12 is, in one preferred embodiment, connected to an articulated arm 36 which allows for flexibility in manipulating and aiming laser device 12 at a particular target. It is to be understood, however, that laser system 10 is not limited to articulated arm 36, and could be mounted in a variety of other configurations, if desired, and/or be handheld by the healthcare provider, if desired.
Furthermore, it is to be understood that the present invention is not limited to the laser device 12 shown, but could be a variety of other sizes, as could also collimator 20, and could be configured for exposing a target 16 of a variety of sizes, including a full body exposure of a patient. Articulated arm 36 is mounted on base 38, although it could
be mounted on a wall, ceiling, floor, examination table, etc., if desired. Also, laser system 10 could be portable, such that it may be carried by hand, and/or mounted on a wheeled cart, or other base, for facilitating transport within a medical facility, in the field, or in other environments. The present invention includes methods and protocols for using laser energy at elevated dosages in order to achieve therapeutic benefit while refraining from damaging the tissue being treated. In practicing the methods of the present invention, the nature and extent of the tissue disorder is first diagnosed and the location, size, and number of treatment area(s) is established. Thereafter, the treatment area(s) is exposed to monochromatic, coherent light below the level necessary to cause thermal damage to the tissue being treated, wherein the light is in the near infrared portion of the electromagnetic spectrum. The treatment area is exposed to the monochromatic, coherent light for a sufficient treatment time to produce clinically beneficial effects by delivering a dosage typically greater than 7 Joules/cm2. As discussed above, monochromatic light refers to light which is of the same wavelength, and coherent means that the waves of light have similar direction, amplitude, and phase to each other. In accordance with a preferred embodiment of the present invention, monochromatic, coherent light having a wavelength in the 600 to 1400 nanometer (nm) range is used in the treatment of soft tissue, bone, and/or body fluids and other disorders by irradiating a treatment area for sufficient time to produce clinically beneficial effects. It is contemplated dosages in the range of approximately 7 Joules/cm2 to approximately 40 Joules/cm2 are preferred, although even higher dosages could be given without departing from the spirit of the present invention.
In one preferred method of the present invention, a dosage of approximately 10 Joules/cm2 is delivered to the tissue. Additional treatments and treatment areas maybe treated as determined by the diagnosing physician or other health care provider.
The wavelength of laser light is the basic electromagnetic wave feature directly linked to the energy of an individual light quantum (photon). Cell culture experiments have indicated that there is selectivity in photo-induced phenomena related to wavelengths. Wavelengths in the range of preferably between 600 to 1400 nm are used in the present invention, although wavelengths in the range of 400 to 10,000 nm could also be used, depending on the particular treatment. Since tissue optical
parameters (reflection, scattering, refraction, absorption and depth penetration) depend on wavelength, a particular light wavelength may affect three-dimensional light distribution in tissue. For example, in a specific wavelength range, the longer wavelength the more light penetration depth. Intensity is the rate of light energy delivery to 1 cm2 of skin or other tissue.
Intensity is measured in milliWatts per cm2 (mW/cm2). Suitable intensities for biostimulation are known to be in the range of from 0.1 to 1 ,000 mW/cm2. As used herein, the term "dose" means the light energy provided to the unit of surface (1 cm2) of target 16 during a single irradiation and measured in J/cm2 or mJ/ cm2. By way of example, a laser generating 10 Watts of output power may be used to deliver optical energy to a 20 cm2 treatment area. This produces an intensity, or power density, of 500 mW/cm2, which is currently the maximum intensity permitted by the U.S. Food and Drug Administration (FDA). It is to be understood, however, that in the event the FDA raises or lowers the maximum allowable intensity, or if the present invention is used in locations where regulations otherwise permit, the methods and apparatus as disclosed herein can be modified as necessary without departing from teachings of the present invention. There are other optical parameters, including the type of the light source, optical power, intensity, dose, frequency and pulse duration, wavelength and bandwidth, beam diameter and divergence, three- dimensional light distribution, etc. which may be selected to provide an optimized protocol to treat the disorder.
The method in accordance with the present invention is adapted for the therapeutic treatment of any of a patient's tissue, which includes muscle, nerve, bone, body fluids (including spinal fluid), epithelial, and/or connective tissues. In accordance with a preferred embodiment, the method is adapted for the relief of acute and chronic soft tissue trauma and to provide musculoskeletal pain management. A wide range of disorders of biological tissue or their symptoms may be treated by laser system 10, including the following:
1. Musculoskeletal conditions, such as: degenerative joint disease, traumatic joint and ligament injury, such as rotator cuff, ankle sprain, knee strain, tennis elbow, golf elbow, TMJ, muscle contusions, bone fracture, fibromyalgia, and costochondritis;
2. Neurological conditions, such as: peripheral neuropathy, reflex sympathetic dystrophy, trigeminal neuralgia, migraine headache, stroke, concussions, plantar fascititis, radiculopathy, spinal injury, peripheral neuropathy, sciatica, traumatic nerve injury, diabetic nerve, restless leg syndrome, and tension and migraine headache;
3. Wound treatment such as: post op healing, decubitis wound sores, burns (first degree and full thickness); stasis ulcers, allergic rashes (example, poison ivy etc.), and insect bites;
4. Pain management, such as: spinal pain from herniated or bulging disc, back pain from musculoskeletal strain, reflex symphatic dystrophy, fibromyalgia, pain from musculoskeletal items listed; and
5. Viral infections, such as: herpes, all types (including mononucleosis) and acquired immune deficiency syndrome (ADDS); and autoimmune diseases, such as: multiple sclerosis, psoriasis, rhumatoid diseases, chronic fatigue syndrome, Parkinson's disease, and lupus.
Treatment in accordance with the present invention is also anticipated to meet with success in treatment of other neurological conditions, such as: stroke, closed head injury, and spinal cord injury; in cardio vascular system conditions, such as: coronary artery disease and peripheral vascular disease; in viral infection applications, such as viral flu syndromes; and in connection with autoimmune diseases, such as diabetes, ALS, and others.
In accordance with one preferred embodiment of the present invention, the tissue to be treated is irradiated with optical energy. The treatment with optical energy is believed to increase microcirculation and creates biostimulative effects at the cellular level. Photobiostimulation occurs when monochromatic, coherent light acts on the photoacceptor molecules within the cells of the tissue being treated.
In accordance with a preferred embodiment, a diode-pumped, solid-state Nd: YAG laser is used as the source of this optical energy, producing optical energy in the form of light at 1064 nm wavelength. This light is guided through fiber optic cable 18 collimator 20 with an aperture sized appropriately for the desired treatment area and the time necessary to cover the treatment area. In accordance with one embodiment, the aperture of collimator 20 is circular, with an area of 10 cm2, and this
embodiment is particularly adapted for application to a treatment target site of approximately 10 cm2.
While laser system 10 is contemplated for use in accordance with the present invention, those skilled in the art will appreciate the variety of other laser systems which may be utilized without departing from the teachings of the present invention.
By way of non-limiting examples, representative methods of the present invention are disclosed below.
After diagnosing the nature and extent of a tissue disorder, the physician preferably establishes the location, size, and number of treatment areas. In one embodiment, the size of the treatment areas is approximately 10 cm2, although the treatment area may range from between approximately 0.1 cm2 to entire body of the patient. Where different treatment sites are contemplated, the laser aperture is accordingly adjusted to accommodate the different treatment site sizes, and the treatment sites are treated by exposing them to monochromatic, coherent light from laser device 12. Larger areas may be treated by moving laser device 12 and collimator over the entire area in a grid-ljke fashion.
It is contemplated the duration for treatment time can be continuous, i.e., up to
24 hours per day, over several days, if necessary. It will be appreciated by those skilled in the art that the treatment may be a single treatment or may be repeated daily, or periodically for a prescribed number of days necessary to produce clinically beneficial effects.
The relationship between various wavelengths of light and the depth of penetration into the patient's tissues has been demonstrated by others. The choice of wavelength used is dependent upon the depth required to treat the affected tissues. A single laser device 12 can be used for tender points, trigger points, selected points in the affected area, points on the skin overlying the treatment target (e.g. tendon, spur, calcification deposit), spinal nerve roots, points on the skin overlying selected nerve pathways and other localized (e.g. acupuncture) points.
If desired, laser device 12 of the present invention may be constructed of flexible plastic (not shown) or other suitable material to be wrapped around the surface contours of the body. Alternatively, the laser device may be formed in the
shape of a ring (not shown), having light sources arranged on its inner surface, to apply treatment to a finger or other extremity- There are different techniques for performing the treatment methods of the present invention, depending on the application. In the contact technique, laser device 12 is applied directly to the skin surface. In the contact with pressure technique, laser device 12 is applied to the skin surface with pressure. This technique allows deeper light penetration to the tissue, since light scattering is generally significantly less in compressed tissue, and light absorption by blood is less because blood is partially squeezed out of the compressed tissue. The scanning technique is used for the treatment of large areas with laser devices. In practicing the scanning technique, the laser device is moved by the health care provider along the skin surface with definite speed and the affected area is irradiated by a laser beam. This technique is used when the area to be treated is large, and preferably involves use of one or more collimators 20. The use of monochromatic, collimated laser light at approximately 1064 nm, at an intensity of 500m W/cm2 , is believed to allow the beneficial effects of laser light to penetrate deeper than heretofore practiced, in that the laser light is not so readily absorbed and dissipated prior to reaching the targeted tissue, which may reach down to the bone. The majority of treatments in accordance with the present invention involve exposing the tissue to at least 7 Joules/cm2 of laser exposure for a period of time sufficient to deliver a laser light dosage of at least 1500 Joules to the tissue, per treatment within a 24 hour period. In certain applications, for example, when treating fever blisters, fibromyalgia, etc., treatments within a 24 hour period may exceed 32,000 Joules, and such treatments may be repeated daily.
Following are examples of the present invention, all of which use laser light at 1064 nm wavelength at an intensity of at 500 mW/cm2, but it is to be understood that the present invention is not limited to such examples and that such examples are presented herein for non-limiting, illustrative purposes:
EXAMPLES Example 1
A 50 year old male presented with a 2-year history of severe pain in feet. He had previously been treated by multiple physicians and podiatric physicians with multiple modality treatment regimens, all without relief of symptoms. These symptoms were primarily pain at night and on early rising. Despite those treatments, the patient, who was on his feet all day as a freight delivery person, was in constant pain. He presented for treatment by referral and was given a total of approximately ten minutes of treatment with a laser over the soles of his feet. After a second treatment of approximately five minutes, the patient was pain-free. He has remained in that state to date without further treatments, and has continued his normal work schedule.
Example 2 The patient presented with chronic neck pain and unable to raise his hands above 90 degrees in the lateral plane without significant pain. He had been to numerous clinics in the past, including pain clinics, chiropractors, etc. without relief. A physical examination revealed bilateral tenderness in both subscapular areas, as well as moderate swelling of the soft tissues. The treatment with a laser included the patient receiving 2 treatments bilaterally along the subscapular region, with total treatment time being approximately 20 minutes in length. There was a five day separation in treatment protocols. The results were that after the third treatment day, there was a 90% reduction in pain with motion, and after the tenth treatment day of treatment, the patient stated he was free of pain and had no movement restrictions.
Example 3
The patient was presumed to have chronic arthritic pain, as no neurological symptoms were present, and an MRI showed no disc disease. The patient had less than 30 degrees of rotation to the left and 45 degrees to the right. The patient received 10 treatments of approximately 20 minutes each to the cervical areas three through seven. At the end of the treatment, the patient had 80 degrees of rotation bilaterally.
Example 4
The patient presented with pain in the left knee, and the diagnosis was that the pain was caused by an old ACL injury which had not been repaired. Pre-treatment parameters included 30 degree flexion and significant pain with ambulation, especially when walking stairs. The patient also experienced difficult ambulation upon rising in the morning. The treatment protocol included the patient receiving ten 20 minute treatments. He received five consecutive treatments, followed by five days without treatment, and then five more similar treatments. Post treatment measurements yielded flexion at 95 degrees with no pain in climbing stairs, no early morning pain, and generally unlimited ambulation.
Example 5
The patient presented two years out post-op for lumbar disc disease. No further surgery was suggested. He was referred for pain relief using the laser protocols. The patient was free of all objective findings, other than the surgical incisions. He complained of severe hyperesthesia over his entire right foot, especially the lateral aspect. The pain was severe enough to cause him to awaken at night when the bed sheets touched his foot. The treatment included the patient receiving a total of ten treatments consisting of five minutes to the L4-S 1 segment of the lumbar spine, as well as five minutes to the areas of hyperesthesia on the right foot. The result was that after completion of the seventh treatment, the patient noted complete resolution of all pain and tenderness.
Example 6 A 60 year old male physician presented with an undiagnosed peripheral neuropathy which manifested with symptoms including loss of sensation and prior perception of his lower extremities. The patient was a prominent physician and on the board of major university medical system, and had undergone multiple tests with numerous specialists. No specific diagnosis was ever established except "peripheral neuropathy". This problem had been present for over 15 years, and the doctor felt that his symptoms were progressing. The treatment protocol consisted of daily exposure to the laser over the entire length of his spinal cord, as well as over the lumbar plexus.
Each session lasted approximately 30 minutes. The length of the total sessions was five days, followed by 10 days of rest, and the process was then repeated. After the second cycle of treatments, the patient reported a significant change is his ability to "feel" his legs. Before the treatment, he could not walk on the beach because he could not tell where his feet were and would fall constantly. Also, before the treatment he could walk on the concrete surface of his pool deck and not feel any heat, and now he must wear shoes to avoid painful burning sensation. He could also walk on the beach without fear of falling.
Example 7
A 55 year old female who was 20 years post-op from an ankle reconstruction, presented with severe ankle pain on the operative ankle. She had multiple screws implanted at the time of surgery. Since then she was in constant pain and could only wear running shoes with the back of the shoes cut out. She could not climb stairs without significant discomfort. Several surgical consultations were sought, and the only advice she was given was a total ankle fusion, which she rejected. She received a total of three treatments to the entire ankle of approximately ten minutes per treatment. She has been free of pain for the last 60 days, and is back wearing normal shoes. From the foregoing, it will be obvious to those skilled in the art that various modifications in the above-described method and apparatus can be made without departing from the spirit and scope of the invention. 'Accordingly, the invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. Present embodiments, therefore, are to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims
1. A method for treating selected tissue, comprising: exposing the selected tissue to laser light having a wavelength between approximately 600 and 1400 run; and maintaining said exposure of the selected tissue to said laser light for a period of time sufficient to deliver a laser light dosage of at least 1 ,000 Joules per treatment to the selected tissue within a 24 hour period of time.
2. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to peripheral neuropathy, reflex sympathetic dystrophy, trigeminal neuralgia, migraine headaches, stroke, concussions, plantar fascititis, radiculophthy, peripheral neuropathy, sciatica, traumatic nerve injury, diabetic nerve, or restless leg syndrome.
3. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to post-operative healing, decubitis wound sores, burns, stasis ulcers, allergic rashes, or insect bites.
4. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to spinal pain from herniated disc, spinal pain from herniated bulging disc, back pain from musculoskeletal strain, reflex symphatic dystrophy, or fibromyalgia.
5. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to herpes, acquired immune deficiency syndrome (ATDS), multiple sclerosis, psoriasis, rhumatoid diseases, chronic fatigue syndrome, Parkinson's disease, or lupus.
6. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to fibromyalgia or costochondritis.
7. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to stroke, closed head injury, or spinal cord injury.
8. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to coronary artery disease or peripheral vascular disease.
9. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to viral flu syndromes or autoimmune diseases.
10. The method as defined in claim 1 , wherein the selected tissue is tissue physiologically linked to diabetes or ALS.
1 1. The method as defined in claim 1 , wherein the selected tissue is musculoskeletal tissue.
12. The method as defined in claim 1, wherein the selected tissue is neurological tissue.
13. The method as defined in claim 1, wherein the selected tissue is wound tissue.
14. The method as defined in claim 1 , wherein the selected tissue is spinal tissue or spinal fluid.
15. A method for treating selected tissue, comprising: exposing the selected tissue to laser light having a wavelength between approximately 600 and 1400 ran; and upcollimating said laser light such that said laser light delivers to the selected tissue a substantially coherent beam of laser light having a cross-sectional area of at least ten cm2.
16. A method for treating selected tissue, comprising: exposing the selected tissue to laser light at a wavelength between approximately 600 and 1400 nm and a power density of at least 30OmW/ cm2; maintaining said exposure of the selected tissue to said laser light for a period of time sufficient to deliver a laser light dosage of at least 7 Joules/cm2 per treatment to the selected tissue; and delivering said laser light to a depth of at least five millimeters in the selected tissue for treating the selected tissue.
17. A method for treating selected tissue, comprising: exposing the selected tissue to laser light at a wavelength of approximately 1064 nm and at a power density of at least 50OmW/ cm2; upcollimating said laser light such that said laser light delivers to the selected tissue a substantially coherent beam of laser light having a cross-sectional area of approximately ten cm2 ; and maintaining said exposure of the selected tissue to said laser light for a period of time sufficient to deliver a laser light dosage of at least 1500 Joules per treatment to the selected tissue within a 24 hour period of time.
18. An apparatus for treating selected tissue, the apparatus comprising: a power source; a processor connected to said power source and having stored treatment protocols suitable for treating a plurality of different selected tissues; means for selecting at least one of said stored treatment protocols for the selected tissue, said treatment protocols including wavelength, power, intensity and dose; a laser device connected to said processor; said laser device including a neodymium doped yttrium-aluminum-vanadate laser configured to deliver a laser beam at a wavelength of between 600 and 1400 nanometers (nm) corresponding to the selected treatment protocol and for directing said laser beam to the selected tissue to be treated; said laser device, said power source, and said processor being configured to provide a generally coherent and monochromatic laser beam having an intensity of 500 mW/cm for treatment of the selected tissue at a dose of at least 7 Joules/cm ; and a collimator connected to said laser device for receiving said laser beam and for upcollimating said laser beam to a cross-section area of at least approximately 10 cm2 while maintaining the laser beam as generally coherent and monochromatic.
19. The apparatus as defined in claim 18, wherein said laser device, said power source, said processor, and said collimator are configured to deliver said generally coherent and monochromatic laser beam to a depth of at least five millimeters in the selected tissue for treating the selected tissue.
20. The apparatus as defined in claim 18, wherein said laser device, said power source, and said processor are configured to deliver said generally coherent and monochromatic laser beam for treatment of the selected tissue at a dose of at least 1,500 Joules.
21. A method for treating selected tissue, comprising: exposing the selected tissue to- laser light having a wavelength between approximately 600 and 1400 nm; and maintaining said exposure of the selected tissue to said laser light for a period of time sufficient to deliver a laser light dosage of at least 1,500 Joules per treatment to the selected tissue within a 24 hour period of time.
22. A method for treating selected tissue, comprising: exposing the selected tissue to laser light having a wavelength between approximately 600 and 1400 nm; and maintaining said exposure of the selected tissue to said laser light for a period of time sufficient to deliver a laser light dosage of at least 2,000 Joules per treatment to the selected tissue within a 24 hour period of time.
23. An apparatus for treating selected tissue, the apparatus comprising: a power source; a processor connected to said power source and having stored treatment protocols suitable for treating a plurality of different selected tissues; means for selecting at least one of said stored treatment protocols for the selected tissue, said treatment protocols including wavelength, power, intensity and dose; a laser device connected to said processor; said laser device including a neodymium doped yttrium-aluminum-garnet laser configured to deliver a laser beam at a wavelength of between 600 and 1400 nanometers (nm) corresponding to the selected treatment protocol and for directing said laser beam to the selected tissue to be treated; said laser device, said power source, and said processor being configured to provide a generally coherent and monochromatic laser beam having an intensity of 500 mW/cm2 for treatment of the selected tissue at a dose of at least 7 Joules/cm2; and a collimator connected to said laser device for receiving said laser beam and for upcollimating said laser beam to a cross-section area of at least approximately 10 cm while maintaining the laser beam as generally coherent and monochromatic.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/329,705 US8033284B2 (en) | 2006-01-11 | 2006-01-11 | Therapeutic laser treatment |
US11/329,705 | 2006-01-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007082047A2 true WO2007082047A2 (en) | 2007-07-19 |
WO2007082047A3 WO2007082047A3 (en) | 2007-11-29 |
Family
ID=38233703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/000786 WO2007082047A2 (en) | 2006-01-11 | 2007-01-11 | Therapeutic laser treatment |
Country Status (2)
Country | Link |
---|---|
US (2) | US8033284B2 (en) |
WO (1) | WO2007082047A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011116413A1 (en) * | 2010-03-22 | 2011-09-29 | Ellex Medical Pty Ltd | Laser immunotherapy |
WO2015108088A1 (en) * | 2014-01-14 | 2015-07-23 | 学校法人 聖マリアンナ医科大学 | Phototherapeutic device for metabolic bone diseases |
Families Citing this family (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7303578B2 (en) | 2001-11-01 | 2007-12-04 | Photothera, Inc. | Device and method for providing phototherapy to the brain |
US8308784B2 (en) | 2006-08-24 | 2012-11-13 | Jackson Streeter | Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease |
US7534255B1 (en) | 2003-01-24 | 2009-05-19 | Photothera, Inc | Low level light therapy for enhancement of neurologic function |
US10695577B2 (en) | 2001-12-21 | 2020-06-30 | Photothera, Inc. | Device and method for providing phototherapy to the heart |
MXPA04011059A (en) | 2002-05-09 | 2005-07-14 | Daemen College | Electrical stimulation unit and waterbath system. |
EP3045136B1 (en) | 2003-09-12 | 2021-02-24 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8033284B2 (en) * | 2006-01-11 | 2011-10-11 | Curaelase, Inc. | Therapeutic laser treatment |
US7575589B2 (en) | 2006-01-30 | 2009-08-18 | Photothera, Inc. | Light-emitting device and method for providing phototherapy to the brain |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US9079762B2 (en) * | 2006-09-22 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Micro-electromechanical device |
ES2560006T3 (en) | 2006-10-18 | 2016-02-17 | Vessix Vascular, Inc. | Induction of desirable temperature effects on body tissue |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
WO2008061197A2 (en) * | 2006-11-15 | 2008-05-22 | National Biological Corporation | Controlled protocol timer |
US7713265B2 (en) | 2006-12-22 | 2010-05-11 | Ethicon Endo-Surgery, Inc. | Apparatus and method for medically treating a tattoo |
US8273015B2 (en) | 2007-01-09 | 2012-09-25 | Ethicon Endo-Surgery, Inc. | Methods for imaging the anatomy with an anatomically secured scanner assembly |
US8801606B2 (en) * | 2007-01-09 | 2014-08-12 | Ethicon Endo-Surgery, Inc. | Method of in vivo monitoring using an imaging system including scanned beam imaging unit |
US8216214B2 (en) | 2007-03-12 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Power modulation of a scanning beam for imaging, therapy, and/or diagnosis |
US20080242967A1 (en) * | 2007-03-27 | 2008-10-02 | Ethicon Endo-Surgery, Inc. | Medical imaging and therapy utilizing a scanned beam system operating at multiple wavelengths |
US8626271B2 (en) * | 2007-04-13 | 2014-01-07 | Ethicon Endo-Surgery, Inc. | System and method using fluorescence to examine within a patient's anatomy |
US7995045B2 (en) * | 2007-04-13 | 2011-08-09 | Ethicon Endo-Surgery, Inc. | Combined SBI and conventional image processor |
US20080275305A1 (en) * | 2007-05-01 | 2008-11-06 | Ethicon Endo-Surgery, Inc. | Medical scanned beam imager and components associated therewith |
US8160678B2 (en) * | 2007-06-18 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for repairing damaged or diseased tissue using a scanning beam assembly |
US20080319507A1 (en) * | 2007-06-25 | 2008-12-25 | Reliant Technologies, Inc. | Tissue Treatment Device and Method of Restricting Use of Device |
US7558455B2 (en) | 2007-06-29 | 2009-07-07 | Ethicon Endo-Surgery, Inc | Receiver aperture broadening for scanned beam imaging |
US7982776B2 (en) | 2007-07-13 | 2011-07-19 | Ethicon Endo-Surgery, Inc. | SBI motion artifact removal apparatus and method |
US9125552B2 (en) | 2007-07-31 | 2015-09-08 | Ethicon Endo-Surgery, Inc. | Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy |
US7983739B2 (en) | 2007-08-27 | 2011-07-19 | Ethicon Endo-Surgery, Inc. | Position tracking and control for a scanning assembly |
US7925333B2 (en) * | 2007-08-28 | 2011-04-12 | Ethicon Endo-Surgery, Inc. | Medical device including scanned beam unit with operational control features |
US20090060381A1 (en) * | 2007-08-31 | 2009-03-05 | Ethicon Endo-Surgery, Inc. | Dynamic range and amplitude control for imaging |
US8050520B2 (en) | 2008-03-27 | 2011-11-01 | Ethicon Endo-Surgery, Inc. | Method for creating a pixel image from sampled data of a scanned beam imager |
US8332014B2 (en) | 2008-04-25 | 2012-12-11 | Ethicon Endo-Surgery, Inc. | Scanned beam device and method using same which measures the reflectance of patient tissue |
US7848035B2 (en) | 2008-09-18 | 2010-12-07 | Photothera, Inc. | Single-use lens assembly |
WO2010056745A1 (en) | 2008-11-17 | 2010-05-20 | Minnow Medical, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US9693825B2 (en) | 2008-12-14 | 2017-07-04 | C Laser, Inc. | Fiber embedded hollow needle for percutaneous delivery of laser energy |
US9414887B2 (en) * | 2009-03-13 | 2016-08-16 | Robert R. Alfano | Method and apparatus for producing supercontinuum light for medical and biological applications |
US20120101557A1 (en) * | 2009-06-24 | 2012-04-26 | Koninklijke Philips Electronics N.V. | Treatment apparatus and use thereof for treating psoriasis |
US8690933B2 (en) * | 2009-08-31 | 2014-04-08 | Brigham Young University | System and method for treating symptoms of restless legs syndrome |
FR2952306B1 (en) * | 2009-11-09 | 2012-03-30 | Creaspine | AQUEOUS COMPOSITION FOR THE TREATMENT OF LASER FIBROUS CONJUNCTIVE TISSUE REPAIR |
US20110172746A1 (en) * | 2010-01-12 | 2011-07-14 | Roger Porter | High Level Laser Therapy Apparatus and Methods |
US9265576B2 (en) | 2010-02-21 | 2016-02-23 | C Laser, Inc. | Laser generator for medical treatment |
US10206742B2 (en) | 2010-02-21 | 2019-02-19 | C Laser, Inc. | Fiber embedded hollow spikes for percutaneous delivery of laser energy |
DE102010009554A1 (en) * | 2010-02-26 | 2011-09-01 | Lüllau Engineering Gmbh | Method and irradiation apparatus for irradiating curved surfaces with non-ionizing radiation |
US8518094B2 (en) * | 2010-03-02 | 2013-08-27 | Bwt Property, Inc. | Precisely guided phototherapy apparatus |
CA2795229A1 (en) | 2010-04-09 | 2011-10-13 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US20120065712A1 (en) * | 2010-09-13 | 2012-03-15 | Intellectual Resources Llc | Cellular stimulation by optical energy |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
WO2012100095A1 (en) | 2011-01-19 | 2012-07-26 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US10786412B2 (en) * | 2011-03-15 | 2020-09-29 | Mark Jagger | Computer controlled laser therapy treatment table |
US9446260B2 (en) | 2011-03-15 | 2016-09-20 | Mark Jagger | Computer controlled laser therapy treatment table |
US10391331B2 (en) | 2011-03-29 | 2019-08-27 | Biolyst, Llc. | Systems and methods for use in treating sensory impairment |
US9486447B2 (en) * | 2011-06-13 | 2016-11-08 | The General Hospital Corporation | Compositions and methods for controlling neuronal excitation |
CN103813745B (en) | 2011-07-20 | 2016-06-29 | 波士顿科学西美德公司 | In order to visualize, be directed at and to melt transcutaneous device and the method for nerve |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN104023662B (en) | 2011-11-08 | 2018-02-09 | 波士顿科学西美德公司 | Hole portion renal nerve melts |
WO2013074813A1 (en) | 2011-11-15 | 2013-05-23 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
EP2797534A1 (en) | 2011-12-28 | 2014-11-05 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013134479A1 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg Sarl | Neuromodulation and associated systems and methods for the management of pain |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
CN104540465A (en) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | Intravascular catheter with a balloon comprising separate microporous regions |
WO2014043687A2 (en) | 2012-09-17 | 2014-03-20 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
WO2014047454A2 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10589120B1 (en) | 2012-12-31 | 2020-03-17 | Gary John Bellinger | High-intensity laser therapy method and apparatus |
US20140207213A1 (en) * | 2013-01-23 | 2014-07-24 | Khalilullah A. Khatri | Laser method for treating hyperhidrosis targeting sweat glands |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
JP6139772B2 (en) | 2013-03-15 | 2017-05-31 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Control unit for use with electrode pads and method for estimating leakage |
WO2014205399A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
CN105473091B (en) | 2013-06-21 | 2020-01-21 | 波士顿科学国际有限公司 | Renal denervation balloon catheter with co-movable electrode supports |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
JP6204579B2 (en) | 2013-07-01 | 2017-09-27 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal nerve ablation medical device |
EP3019106A1 (en) | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
CN105377169B (en) | 2013-07-11 | 2019-04-19 | 波士顿科学国际有限公司 | Device and method for neuromodulation |
WO2015010074A1 (en) | 2013-07-19 | 2015-01-22 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
CN105392435B (en) | 2013-07-22 | 2018-11-09 | 波士顿科学国际有限公司 | Renal nerve ablation catheter with twisting sacculus |
CN105473093B (en) | 2013-08-22 | 2019-02-05 | 波士顿科学国际有限公司 | Flexible circuit with the improved adhesion strength to renal nerve modulation sacculus |
CN105555218B (en) | 2013-09-04 | 2019-01-15 | 波士顿科学国际有限公司 | With radio frequency (RF) foley's tube rinsed with cooling capacity |
EP3043733A1 (en) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
WO2015057521A1 (en) | 2013-10-14 | 2015-04-23 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
JP6259098B2 (en) | 2013-10-15 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device and method for manufacturing the medical device |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
WO2015061457A1 (en) | 2013-10-25 | 2015-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
CN105899157B (en) | 2014-01-06 | 2019-08-09 | 波士顿科学国际有限公司 | Tear-proof flexible circuit assembly |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9907975B1 (en) * | 2014-11-19 | 2018-03-06 | Roger D. Porter | Therapeutic laser treatment and transdermal stimulation of stem cell differentiation |
CN105310782B (en) * | 2015-11-04 | 2017-08-25 | 庄源东 | Surgical laser alignment system |
US10780296B2 (en) | 2017-09-01 | 2020-09-22 | Reni-Zoe Zivin | Transcranial laser therapy for treatment of acute ischemic stroke |
EP3703816A4 (en) * | 2017-10-30 | 2021-08-11 | Medical Quant USA dba Multi Radiance Medical | Photobiomodulation therapy to ameliorate multiple sclerosis |
US11202674B2 (en) | 2018-04-03 | 2021-12-21 | Convergent Dental, Inc. | Laser system for surgical applications |
WO2021155054A1 (en) * | 2020-01-31 | 2021-08-05 | Enamel Pure, Llc | Preventative dental hard tissue laser treatment systems, methods, and computer-readable media |
CN111408076B (en) * | 2020-04-13 | 2022-02-08 | 耿再芳 | Multifunctional gynecological clinical ultrasonic therapeutic apparatus |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5140984A (en) * | 1983-10-06 | 1992-08-25 | Proclosure, Inc. | Laser healing method and apparatus |
US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
US5527350A (en) * | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
US6273905B1 (en) * | 1999-03-23 | 2001-08-14 | Jackson Streeter | Method for treating spinal cord transection |
US6302900B1 (en) * | 2000-03-15 | 2001-10-16 | Jeffrey M. Riggs | Holistic method of treating injured or pathologic tissue with a laser |
US6527797B1 (en) * | 1996-02-13 | 2003-03-04 | El.En S.P.A. | Laser device for treatment of painful symptomatologies and associated method |
US6845111B2 (en) * | 2002-09-20 | 2005-01-18 | Hrl Laboratories, Llc | Laser apparatus with improved thermal stress resistance |
US20050245998A1 (en) * | 2004-04-30 | 2005-11-03 | Led Healing Light, Llc | Hand held pulse laser for therapeutic use |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769963A (en) | 1972-03-31 | 1973-11-06 | L Goldman | Instrument for performing laser micro-surgery and diagnostic transillumination of living human tissue |
IL40603A (en) * | 1972-10-17 | 1975-12-31 | Laser Ind Ltd | Laser device with articulated arm |
US4069823A (en) * | 1976-04-19 | 1978-01-24 | Viktor Leonidovich Isakov | Apparatus for laser therapy |
US4215694A (en) * | 1978-06-01 | 1980-08-05 | Isakov Viktor L | Laser therapy apparatus |
HU186081B (en) * | 1981-09-02 | 1985-05-28 | Fenyo Marta | Process and apparatus for stimulating healing of pathologic points on the surface of the body first of all of wounds, ulcera and other epithelial lesions |
US4669839A (en) * | 1983-09-16 | 1987-06-02 | Carl-Zeiss-Stiftung | Optical system for therapeutic use of laser light |
US4672969A (en) * | 1983-10-06 | 1987-06-16 | Sonomo Corporation | Laser healing method |
US5002051A (en) * | 1983-10-06 | 1991-03-26 | Lasery Surgery Software, Inc. | Method for closing tissue wounds using radiative energy beams |
US4854320A (en) | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US5409479A (en) * | 1983-10-06 | 1995-04-25 | Premier Laser Systems, Inc. | Method for closing tissue wounds using radiative energy beams |
JPS60132571A (en) * | 1983-12-19 | 1985-07-15 | 澁谷工業株式会社 | Treatment of dermatophytosis |
US4724835A (en) * | 1984-03-06 | 1988-02-16 | Pain Suppression Labs, Inc. | Laser therapeutic device |
JPS60232176A (en) * | 1984-04-20 | 1985-11-18 | ジユデイス ウオーカー エム.デイ. | Treatment apparatus by laser beam |
CA1253922A (en) * | 1984-12-24 | 1989-05-09 | Kimimoto Nakai | Apparatus for treating athlete's foot |
JPS633873A (en) * | 1986-06-23 | 1988-01-08 | 富士電機株式会社 | Laser remedy device |
EP0263193A1 (en) * | 1986-10-04 | 1988-04-13 | Helmut K. Pinsch GmbH & Co. | Method and apparatus for increasing the well-being of a living being |
JPS63130075A (en) * | 1986-11-19 | 1988-06-02 | 富士電機株式会社 | Laser medical treatment device |
IL82830A (en) * | 1987-06-09 | 1992-03-29 | Simeone Rochkind | Apparatus for inducing functional regeneration of nerve fibres at an injured site of the spinal cord |
DE3729208C1 (en) * | 1987-08-29 | 1988-12-22 | Rotring Werke Riepe Kg | Cutting device |
US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US5242437A (en) * | 1988-06-10 | 1993-09-07 | Trimedyne Laser Systems, Inc. | Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium |
US5021452A (en) * | 1989-01-09 | 1991-06-04 | The Board Of Regents Of The University Of Washington | Process for enhancing wound healing |
GB2242307B (en) * | 1990-02-09 | 1994-09-07 | Omega Universal Tech Ltd | Laser probe for biomodulation of tissue nerve and immune systems |
US5951596A (en) * | 1991-07-01 | 1999-09-14 | Laser Biotherapy Inc | Biological tissue stimulation by optical energy |
US5320619A (en) * | 1991-12-24 | 1994-06-14 | Badawi Radwan A | Laser dosimeter and positioner, and methods of constructing and utilizing same |
IL100545A (en) * | 1991-12-29 | 1995-03-15 | Dimotech Ltd | Apparatus for photodynamic therapy treatment |
US5755752A (en) * | 1992-04-24 | 1998-05-26 | Segal; Kim Robin | Diode laser irradiation system for biological tissue stimulation |
US5807881A (en) * | 1992-05-27 | 1998-09-15 | Quadra Logic Technologies, Inc. | Method for selectively reducing activated leukocyte cell population |
US5707403A (en) * | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US6156028A (en) * | 1994-03-21 | 2000-12-05 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment of wounds |
US5616140A (en) * | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
US20030114902A1 (en) * | 1994-03-21 | 2003-06-19 | Prescott Marvin A. | Laser therapy for foot conditions |
US5464436A (en) | 1994-04-28 | 1995-11-07 | Lasermedics, Inc. | Method of performing laser therapy |
US5514168A (en) * | 1994-05-20 | 1996-05-07 | Friedman; Mark H. | Treatment of vascular headache and atypical facial pain |
US5792215A (en) * | 1995-09-18 | 1998-08-11 | The University Of Virginia Patent Foundation | Laser integrated targeting and entry system and method |
US20010034517A1 (en) | 1996-02-13 | 2001-10-25 | El.En. S.P.A. | Device and method for biological tissue stimulation by high intensity laser therapy |
US20040010300A1 (en) | 1996-02-13 | 2004-01-15 | Leonardo Masotti | Device and method for biological tissue stimulation by high intensity laser therapy |
US20070185552A1 (en) | 1996-02-13 | 2007-08-09 | Leonardo Masotti | Device and method for biological tissue stimulation by high intensity laser therapy |
KR100376650B1 (en) * | 1996-04-09 | 2003-08-25 | 싸이노슈어, 인코포레이티드 | Alexander laser system for the treatment of skin pathological specimens |
US7036516B1 (en) * | 1996-10-30 | 2006-05-02 | Xantech Pharmaceuticals, Inc. | Treatment of pigmented tissues using optical energy |
US6162211A (en) * | 1996-12-05 | 2000-12-19 | Thermolase Corporation | Skin enhancement using laser light |
US6063108A (en) * | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
US20090069872A1 (en) * | 1997-02-10 | 2009-03-12 | El. En. S.P.A. | Device and method for biological tissue stimulation by high intensity laser therapy |
US6090101A (en) * | 1997-12-10 | 2000-07-18 | Quon; David K. | Method and apparatus for permanent hair removal |
AU1934699A (en) * | 1998-01-07 | 1999-07-26 | Kim Robin Segal | Diode laser irradiation and electrotherapy system for biological tissue stimulation |
US6221068B1 (en) * | 1998-01-15 | 2001-04-24 | Northwestern University | Method for welding tissue |
US6066129A (en) * | 1998-01-29 | 2000-05-23 | Larson; Dean W. | Medical laser control system |
US6084242A (en) * | 1998-07-06 | 2000-07-04 | Brown, Jr. Doyle S. | Method and device for stimulating the immune system and generating healing at the cellular level |
US6165205A (en) | 1998-07-10 | 2000-12-26 | Ceramoptec Industries, Inc. | Method for improved wound healing |
US6663659B2 (en) * | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
US6676655B2 (en) * | 1998-11-30 | 2004-01-13 | Light Bioscience L.L.C. | Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen |
US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
US6183773B1 (en) * | 1999-01-04 | 2001-02-06 | The General Hospital Corporation | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
AU3147200A (en) * | 1999-03-08 | 2000-09-28 | Asah Medico A/S | An apparatus for tissue treatment and having a monitor for display of tissue features |
US6267779B1 (en) * | 1999-03-29 | 2001-07-31 | Medelaser, Llc | Method and apparatus for therapeutic laser treatment |
US6203956B1 (en) * | 1999-04-07 | 2001-03-20 | Fuji Xerox Co., Ltd. | Electrophotographic toner and image-forming method |
US6413267B1 (en) * | 1999-08-09 | 2002-07-02 | Theralase, Inc. | Therapeutic laser device and method including noninvasive subsurface monitoring and controlling means |
US6503268B1 (en) * | 2000-04-03 | 2003-01-07 | Ceramoptec Industries, Inc. | Therapeutic laser system operating between 1000nm and 1300nm and its use |
US6569156B1 (en) * | 2000-06-30 | 2003-05-27 | Nikolai Tankovich | Medical cosmetic laser with second wavelength enhancement |
US6592611B1 (en) * | 2000-10-10 | 2003-07-15 | Robert H. Zawada | Violation of time reversal invariance in living tissue |
US6554824B2 (en) * | 2000-12-15 | 2003-04-29 | Laserscope | Methods for laser treatment of soft tissue |
US7351252B2 (en) * | 2002-06-19 | 2008-04-01 | Palomar Medical Technologies, Inc. | Method and apparatus for photothermal treatment of tissue at depth |
US6746473B2 (en) * | 2001-03-02 | 2004-06-08 | Erchonia Patent Holdings, Llc | Therapeutic laser device |
US7033348B2 (en) * | 2001-04-10 | 2006-04-25 | The Research Foundation Of The City University Of New York | Gelatin based on Power-gel™ as solders for Cr4+laser tissue welding and sealing of lung air leak and fistulas in organs |
GB0111271D0 (en) * | 2001-05-09 | 2001-06-27 | Asclepion Meditec Ltd | A method of stimulating collagen formation |
US7094252B2 (en) * | 2001-08-21 | 2006-08-22 | Cooltouch Incorporated | Enhanced noninvasive collagen remodeling |
US8287524B2 (en) * | 2001-08-23 | 2012-10-16 | Jerry Siegel | Apparatus and method for performing radiation energy treatments |
US7160287B1 (en) * | 2001-08-23 | 2007-01-09 | Jerry Siegel | Apparatus and method for performing radiation energy treatments |
US7303578B2 (en) | 2001-11-01 | 2007-12-04 | Photothera, Inc. | Device and method for providing phototherapy to the brain |
US7762964B2 (en) | 2001-12-10 | 2010-07-27 | Candela Corporation | Method and apparatus for improving safety during exposure to a monochromatic light source |
EP1627662B1 (en) | 2004-06-10 | 2011-03-02 | Candela Corporation | Apparatus for vacuum-assisted light-based treatments of the skin |
US7762965B2 (en) * | 2001-12-10 | 2010-07-27 | Candela Corporation | Method and apparatus for vacuum-assisted light-based treatments of the skin |
EP1829496A2 (en) * | 2001-12-10 | 2007-09-05 | Inolase 2002 Ltd. | Eyesafe hair removal method and apparatus |
US7177695B2 (en) | 2001-12-17 | 2007-02-13 | Cefamoptec Industries, Inc. | Early stage wound healing using electromagnetic radiation |
US20030181962A1 (en) * | 2002-02-19 | 2003-09-25 | Jackson Streeter | Low power energy therapy methods for bioinhibition |
US7081128B2 (en) * | 2002-03-04 | 2006-07-25 | Hart Barry M | Phototherapy device and method of use |
US20050177093A1 (en) * | 2002-03-04 | 2005-08-11 | Barry Hart M. | Joint / tissue inflammation therapy and monitoring device |
JP4113442B2 (en) * | 2002-05-09 | 2008-07-09 | ローム株式会社 | Semiconductor laser, manufacturing method thereof, and optical pickup device |
US7713294B2 (en) * | 2002-08-28 | 2010-05-11 | Nomir Medical Technologies, Inc. | Near infrared microbial elimination laser systems (NIMEL) |
KR100452825B1 (en) * | 2002-12-27 | 2004-10-15 | 삼성전기주식회사 | liner channel select filter |
US8118032B2 (en) | 2003-02-14 | 2012-02-21 | American Environmental Systems, Inc. | Rapid cryo-heating devices and their applications |
US7703458B2 (en) * | 2003-02-21 | 2010-04-27 | Cutera, Inc. | Methods and devices for non-ablative laser treatment of dermatologic conditions |
EP1596745B1 (en) * | 2003-02-25 | 2016-02-17 | Tria Beauty, Inc. | Self-contained, diode-laser-based dermatologic treatment apparatus |
JP2007531544A (en) * | 2003-07-11 | 2007-11-08 | リライアント・テクノロジーズ・インコーポレイテッド | Method and apparatus for fractionated light treatment of skin |
US20050015077A1 (en) * | 2003-07-14 | 2005-01-20 | Yevgeniy Kuklin | Method and apparatus for skin treatment using near infrared laser radiation |
US20050065577A1 (en) * | 2003-09-23 | 2005-03-24 | Mcarthur Frank G. | Low level laser tissue treatment |
US20050137656A1 (en) * | 2003-12-23 | 2005-06-23 | American Environmental Systems, Inc. | Acoustic-optical therapeutical devices and methods |
US7328708B2 (en) * | 2003-12-23 | 2008-02-12 | United Laboratories & Manufacturing, Llc | LED multiplex source and method of use of for sterilization, bioactivation and therapy |
JP4971133B2 (en) * | 2004-04-01 | 2012-07-11 | ザ ジェネラル ホスピタル コーポレイション | Equipment for dermatological treatment |
US20060009823A1 (en) * | 2004-07-08 | 2006-01-12 | Richardson Brian D | Luminex® laser therapy system |
WO2006125231A2 (en) * | 2005-05-17 | 2006-11-23 | Photon Therapy Systems (Proprietary) Limited | A photon therapy device |
US7217265B2 (en) * | 2005-05-18 | 2007-05-15 | Cooltouch Incorporated | Treatment of cellulite with mid-infrared radiation |
US20070100401A1 (en) * | 2005-11-01 | 2007-05-03 | Lin J T | Compact laser device and method for hair removal |
US8033284B2 (en) * | 2006-01-11 | 2011-10-11 | Curaelase, Inc. | Therapeutic laser treatment |
KR100799524B1 (en) | 2006-02-28 | 2008-01-31 | 전용규 | An applicator in a device for treating skin |
US8152796B2 (en) * | 2006-12-12 | 2012-04-10 | Mcmillan Marion R | Method and apparatus for performing percutaneous laser disc decompression with vaporization monitoring by fluid displacement |
US20080234669A1 (en) * | 2007-03-19 | 2008-09-25 | Kauvar Arielle N B | Method and device for treating skin by superficial coagulation |
-
2006
- 2006-01-11 US US11/329,705 patent/US8033284B2/en not_active Expired - Fee Related
-
2007
- 2007-01-11 WO PCT/US2007/000786 patent/WO2007082047A2/en active Application Filing
-
2011
- 2011-09-23 US US13/242,892 patent/US8316860B1/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5140984A (en) * | 1983-10-06 | 1992-08-25 | Proclosure, Inc. | Laser healing method and apparatus |
US5527350A (en) * | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
US6527797B1 (en) * | 1996-02-13 | 2003-03-04 | El.En S.P.A. | Laser device for treatment of painful symptomatologies and associated method |
US6273905B1 (en) * | 1999-03-23 | 2001-08-14 | Jackson Streeter | Method for treating spinal cord transection |
US6302900B1 (en) * | 2000-03-15 | 2001-10-16 | Jeffrey M. Riggs | Holistic method of treating injured or pathologic tissue with a laser |
US6845111B2 (en) * | 2002-09-20 | 2005-01-18 | Hrl Laboratories, Llc | Laser apparatus with improved thermal stress resistance |
US20050245998A1 (en) * | 2004-04-30 | 2005-11-03 | Led Healing Light, Llc | Hand held pulse laser for therapeutic use |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011116413A1 (en) * | 2010-03-22 | 2011-09-29 | Ellex Medical Pty Ltd | Laser immunotherapy |
US8936028B2 (en) | 2010-03-22 | 2015-01-20 | Malcolm Plunkett | Laser immunotherapy |
WO2015108088A1 (en) * | 2014-01-14 | 2015-07-23 | 学校法人 聖マリアンナ医科大学 | Phototherapeutic device for metabolic bone diseases |
JPWO2015108088A1 (en) * | 2014-01-14 | 2017-03-23 | 学校法人 聖マリアンナ医科大学 | Phototherapy device for metabolic bone disease |
Also Published As
Publication number | Publication date |
---|---|
US8033284B2 (en) | 2011-10-11 |
US8316860B1 (en) | 2012-11-27 |
US20070162093A1 (en) | 2007-07-12 |
WO2007082047A3 (en) | 2007-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8316860B1 (en) | Therapeutic laser treatment method | |
US6494900B1 (en) | Method for localized low energy photon therapy (LEPT) | |
US7559945B2 (en) | Multi-spectral photon therapy device and methods of use | |
US8435273B2 (en) | High powered light emitting diode photobiology device | |
Basford et al. | A randomized controlled evaluation of low-intensity laser therapy: plantar fasciitis | |
US6366802B1 (en) | Photon irradiation human pain treatment monitored by thermal imaging | |
US20150112411A1 (en) | High powered light emitting diode photobiology compositions, methods and systems | |
US20070129776A1 (en) | External wearable light therapy treatment systems | |
US10363430B2 (en) | Therapeutic laser treatment and transdermal stimulation of stem cell differentiation | |
Montes-Molina et al. | Efficacy of interferential low-level laser therapy using two independent sources in the treatment of knee pain | |
Bissell | Therapeutic modalities in hand surgery | |
KR101526696B1 (en) | An irradiation device including support assembly | |
CA2775529C (en) | High powered light emitting diode photobiology device | |
RU2294225C1 (en) | Method for treating peripheral nervous lesions | |
US20240108407A1 (en) | Therapeutic laser system and method of use for activating the tissue stem cell niche for the treatment of medical conditions | |
US11369802B2 (en) | Methods and systems for the therapeutic application of laser and cannabidiol to the skin | |
Ye et al. | Thermal tomography imaging in photonic traditional Chinese medicine information therapy with holistic effect for health whole nursing | |
Yumul et al. | Nonpharmacologic analgesic therapies: A focus on photobiomodulation, acustimulation, and cryoanalgesia (ice) therapy | |
KR200238930Y1 (en) | A physical therapy device equipped with a light iris to adjust the width of the irradiated light source by vibrating and integrating the infrared and laser light sources simultaneously. | |
Kohli et al. | Low Level Laser Therapy in Acupuncture Mode for Management of Pain due to DeQuervain's Disease | |
Johnson | Laser therapy and its role in pain management and rehabilitation. | |
LS | Use of lasers in the management of temporomandibular disorders | |
Al-sharify | The biological effects of low level laser therapy with static magnetic field on acute and chronic pain | |
WO2023228206A1 (en) | Musculoskeletal pain reliever for acute and chronic pain | |
Riegel et al. | Clinical Overview and Applications of Class IV Therapy Lasers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07709720 Country of ref document: EP Kind code of ref document: A2 |